Understanding Eye Pressure

What is eye pressure, and how is it different in

open-angle glaucoma and ocular hypertension?

I have been diagnosed with:

Start saving now

Eligible* commercially insured patients may
pay as little as a 
 $25 COPAY FOR UP TO
A 90-DAY SUPPLY For first Rx and eligible refills

START SAVING NOW

open-angle glaucoma

What is open-angle glaucoma?

Open-angle glaucoma occurs when the fluid in one or both of your eyes does not drain properly. It increases the pressure in your eye, which can damage the optic nerve. If left untreated, open-angle glaucoma gradually causes vision loss.

Eye with glaucoma

What happens to the eye with glaucoma.

While there is no way to reverse vision loss, early detection and treatment can help preserve sight.

Have open-angle glaucoma? You’re not alone

Open-angle glaucoma:

  • Is the most common form of glaucoma

  • Does not have any early warning signs or symptoms

  • Causes a slow, irreversible loss in peripheral (side) vision or central field vision

Slide to view examples of vision loss in glaucoma

Loss in peripheral (side) vision

Loss in central field vision

Glaucoma affects more than 80 million people throughout the world.

OCULAR HYPERTENSION

What is ocular hypertension?

Ocular hypertension:

  • Is the medical term used when the pressure in the eye is higher than normal

  • Is caused when the fluid in the eye does not drain properly

  • Can increase the risk of glaucoma and should be monitored carefully

  • Is treated by lowering eye pressure, which may slow or prevent vision loss

Ocular hypertension usually has no signs or symptoms but can be detected via routine testing by an eye care professional.

Lowering eye pressure is straightforward with VYZULTA; just one drop, once daily in the evening.

Not an actual patient.

  • Woman in a yoga pose gesturing V with her fingers.vyzulta-vshape-yoga
  • Join our VYZULTA Community!

    By submitting your information you confirm you have read and agree with the terms of our privacy policy and legal notice.

    By submitting your information you confirm you have read and agree with the terms of our privacy policy and legal notice.

Not an actual patient.

INDICATION

VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION

  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.
  • Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued.
  • Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.
  • Tell your doctor immediately about any change in your eye, any eye condition that develops, any sudden change in your vision, any eye side effects, or if you have eye surgery.
  • Remove contact lenses before putting VYZULTA in your eyes. Lenses may be reinserted 15 minutes later.
  • If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.
  • The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here to see full Prescribing Information.

*Terms, conditions, and limitations apply. Available exclusively at Walgreens or other participating pharmacies. At non-participating pharmacies, eligible patients may pay as little as a $35 copay. Please see eligibility criteria and terms and conditions at BauschAccessProgram.com. Ninety-day supply to be prescribed as 3 bottles of 2.5 mL solution each. Ninety-day supply copay offer only applies if each of the three 2.5-mL bottles is covered by a patient's commercial insurance.
Eligibility criteria/terms and conditions: By using the Bausch + Lomb Access coupon, you confirm that you understand and agree to comply with the following terms and conditions of this offer: This offer is only valid for eligible patients with commercial insurance and eligible uninsured patients. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. Click here for full eligibility criteria.
SEE MOREExpand

INDICATION

VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION

  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.